Detailansicht

Wissensnetz

Person

Marcus Schmidt

Gynäkologe

Name	Marcus Schmidt
Ort	Mainz (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. med.
Beruf	Gynäkologe (charakteristischer Beruf) Onkologe
Variante	M. Schmidt
Weitere Angaben	Diss. Humanmedizin an der Universität Mainz (1995); Habil.-Schr. Medizin (Klinik und Poliklinik für Geburtshilfe und Frauenheilkunde) an der Universität Mainz (2010)
Datensatztyp	Person
GND-Nummer	1016470517
Datensatz-ID	1016470517
Beteiligt an alle anzeigen Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric study Antikörper-Wirkstoff-Konjugate beim metastasierten Mammakarzinom : Eine vielversprechende Behandlungsstrategie Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study Chemotherapy in older patients with early breast cancer Personalisierte Medizin – von der Translation zur Klinik Progesterone from ovulatory menstrual cycles is an important cause of breast cancer PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant Personalisierte Medizin – von der Translation zur Klinik A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth Prognostische Faktoren bei Patientinnen mit Mammakarzinom und leptomeningealen Metastasen: eine Subanalyse des deutschen Registers für Hirnmetastasen beim Mammakarzinom – Versorgungsforschungspreis der DGS 2023 – eine Kurzübersicht AGO-Empfehlungen zur operativen Therapie des Mammakarzinoms: Update 2022 Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response Breast Cancer Outcome: What Have We Achieved AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023 Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023 Elacestrant : erster oraler SERD speziell für die Therapie von lokal fortgeschrittenem oder metastasiertem ER+/HER2-Brustkrebs mit ESR1-Mutationen Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer: controversies and standards in healthcare Vakzinierungsstrategien beim Mammakarzinom Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021 Metronomic Chemotherapy for Metastatic Breast Cancer New Opportunities in Advanced Breast Cancer G-8 Geriatric Screening Tool Independently Predicts Progression-Free Survival in Older Ovarian Cancer Patients Irrespective of Maximal Surgical Effort: Results of a Retrospective Cohort Study AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022 Ago recommendations for the surgical therapy of breast cancer: update 2022 AGO Recommendations for the surgical therapy of breast cancer: update 2022 Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients : a retrospective cohort study in Germany (ESCaRa) Role of integrins in the metastatic spread of high-grade serous ovarian cancer Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference : Substudy of the randomised phase III GAIN-2 study Role of integrins in the metastatic spread of high-grade serous ovarian cancer Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa) Erratum zu: Zielgerichtete Therapie beim metastasierten Mammakarzinom – welche molekularen Tests sind notwendig? Update Immunonkologie beim triple-negativen Mammakarzinom Agnostische Tumortherapie – was ist das? Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046 Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center AGO-Algorithmen zur Behandlung von Brustkrebs: Update 2021 Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update AGO Algorithms for the Treatment of Breast Cancer: Update 2021 Prognostic Impact of Immunoglobulin Kappa C in Breast Cancer Patients Treated with Adjuvant Chemotherapy AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 AGO Algorithms for the Treatment of Breast Cancer: Update 2021 AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 Update

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Marcus Schmidt

Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric study

Antikörper-Wirkstoff-Konjugate beim metastasierten Mammakarzinom : Eine vielversprechende Behandlungsstrategie

Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study

Chemotherapy in older patients with early breast cancer

Personalisierte Medizin – von der Translation zur Klinik

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer

Personalisierte Medizin – von der Translation zur Klinik

A questionnaire-based survey on the diagnostic and therapeutic approaches for patients with STIC in Germany

Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth

Prognostische Faktoren bei Patientinnen mit Mammakarzinom und leptomeningealen Metastasen: eine Subanalyse des deutschen Registers für Hirnmetastasen beim Mammakarzinom – Versorgungsforschungspreis der DGS 2023 – eine Kurzübersicht

AGO-Empfehlungen zur operativen Therapie des Mammakarzinoms: Update 2022

Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare

Anti-tumor effects of low-dose metronomic vinorelbine in combination with alpelisib in breast cancer cells

Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response

Breast Cancer Outcome: What Have We Achieved

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023

Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023

Elacestrant : erster oraler SERD speziell für die Therapie von lokal fortgeschrittenem oder metastasiertem ER+/HER2-Brustkrebs mit ESR1-Mutationen

Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer – controversies and standards in healthcare

Systemic therapy of premenopausal patients with early stage hormone receptor-positive, HER2-negative breast cancer: controversies and standards in healthcare

Vakzinierungsstrategien beim Mammakarzinom

Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study

Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study

Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study

The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study

AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021

Metronomic Chemotherapy for Metastatic Breast Cancer

New Opportunities in Advanced Breast Cancer

G-8 Geriatric Screening Tool Independently Predicts Progression-Free Survival in Older Ovarian Cancer Patients Irrespective of Maximal Surgical Effort: Results of a Retrospective Cohort Study

AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Ago recommendations for the surgical therapy of breast cancer: update 2022

AGO Recommendations for the surgical therapy of breast cancer: update 2022

Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients : a retrospective cohort study in Germany (ESCaRa)

Role of integrins in the metastatic spread of high-grade serous ovarian cancer

Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference : Substudy of the randomised phase III GAIN-2 study

Role of integrins in the metastatic spread of high-grade serous ovarian cancer

Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa)

Erratum zu: Zielgerichtete Therapie beim metastasierten Mammakarzinom – welche molekularen Tests sind notwendig?

Update Immunonkologie beim triple-negativen Mammakarzinom

Agnostische Tumortherapie – was ist das?

Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046

Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center

AGO-Algorithmen zur Behandlung von Brustkrebs: Update 2021

Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

Prognostic Impact of Immunoglobulin Kappa C in Breast Cancer Patients Treated with Adjuvant Chemotherapy

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

AGO Algorithms for the Treatment of Breast Cancer: Update 2021

AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 Update